Edgewise Therapeutics, Inc. - 8-K Filing
Edgewise Therapeutics sold its sevasemten muscular dystrophy program to Servier for $1.55B upfront and up to $2.65B in total, becoming a cardiovascular-focused company.
Tickers: $EWTX
More Regulatory news
- SusGlobal Energy Corp. - 10-Q Filing
- Ideal Power Inc. - 8-K Filing
- DIGI INTERNATIONAL INC - 8-K Filing
- ZeroStack Corp. - 8-K Filing
- Sound Point Meridian Capital, Inc. - 8-K Filing
- Boost Run Inc. - 8-K Filing
- INTERFACE INC - 8-K Filing
- Neonode Inc. - 10-Q Filing
- Virtuix Holdings Inc. - 8-K Filing
- Neonode Inc. - 8-K Filing